| Bioactivity | di-Ellipticine-RIBOTAC is a dual-function small molecule that reduces c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo amyotrophic lateral sclerosis (ALS ) models. |
| Name | di-Ellipticine-RIBOTAC |
| CAS | 2767983-76-4 |
| Formula | C78H87N7O16S |
| Molar Mass | 1410.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bush JA, et al. Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models. Sci Transl Med. 2021 Oct 27;13(617):eabd5991. |
di-Ellipticine-RIBOTAC
CAS: 2767983-76-4 F: C78H87N7O16S W: 1410.63
di-Ellipticine-RIBOTAC is a dual-function small molecule that reduces c9ALS/FTD r(G4C2) repeat expansion in vitro and in
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.